Warner Chilcott Sues Watson for Infringement of Loestrin(R) 24 Fe Patent (PR Newswire via Yahoo! Finance)
Warner Chilcott Company, Inc. announced today that it has filed suit against Watson Laboratories, Inc. and Watson Pharmaceuticals, Inc. in the United States District Court for the District of New Jersey alleging infringement of Warner Chilcott's U.S. patent that protects Loestrin 24 Fe.

Critical Therapeutics Submits New Drug Application for Controlled-Release Formulation of Zileuton To FDA (Business Wire via Yahoo! Finance)
LEXINGTON, Mass.----July 31, 2006--Critical Therapeutics, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for the twice daily, controlled-release formulation of zileuton .

Aurobindo receives US FDA approval for ARV combination (PharmaBiz)
Aurobindo Pharma Ltd received the tentative NDA approval for fixed drug combination product containing Lamivudine150 mg+2idovudine300 mg tablets co packaged with Abacavir 300 mg tablets (NDA) used in the treatment of HIV-1 infection. The three drugs are now available in one single pack.